- £106.57m
- £71.70m
- £4.80m
Director/PDMR Shareholding
Issue of Equity and Total Voting Rights and Capital
Directorate Notification
Issue of Equity and Total Voting Rights and Capital
Annual Financial Report
Issue of Equity and Total Voting Rights and Capital
Closure of the Company's offer
Change of Allotment Date
Stock Exch Notice - Admission to Trading - 01/11/2022
Official List - Official List Notice
Stock Exch Notice - Admission to Trading - 01/08/2022
Stock Exch Notice - Admission to Trading - 12/04/2022
Official List - Official List Notice
Stock Exch Notice - Admission to Trading - 02/03/2022
Official List - Official List Notice
AIM - Schedule One Update - Arecor Therapeutics Plc
Brief: Kings Arms Yard Unaudited NAV As At Sept. 30 Was 69.59 Mln Stg